AKAR, S. Et Al. 2018. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. ARTHRITIS CARE & RESEARCH , vol.70, no.7 , 1090-1094.

AKAR, S., Cetin, P., KALYONCU, U., KARADAĞ, Ö., Sari, I., Cinar, M., ... Yilmaz, S.(2018). Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. ARTHRITIS CARE & RESEARCH , vol.70, no.7, 1090-1094.

AKAR, SERVET Et Al. "Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients," ARTHRITIS CARE & RESEARCH , vol.70, no.7, 1090-1094, 2018

AKAR, SERVET Et Al. "Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients." ARTHRITIS CARE & RESEARCH , vol.70, no.7, pp.1090-1094, 2018

AKAR, S. Et Al. (2018) . "Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients." ARTHRITIS CARE & RESEARCH , vol.70, no.7, pp.1090-1094.

@article{article, author={SERVET AKAR Et Al. }, title={Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients}, journal={ARTHRITIS CARE & RESEARCH}, year=2018, pages={1090-1094} }